Home › Psychomotor Agitation › New York
Psychomotor Agitation clinical trials in New York
4 studies for Psychomotor Agitation are looking for participants at sites in New York.
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1656, New Windsor
- Local Institution - 2619, Staten Island
- Local Institution - 1658, Woodmere
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229Neurosteer Bedside Monitoring System
- Mount Sinai Hospital, New York
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06718764A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2647, Brooklyn
- Richmond Behavioral Associates, Staten Island
- Walnut Clinical Research, Valley Stream
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University at Buffalo - UBMD Neurology, Buffalo
- The Feinstein Institute for Medical Research, Manhasset
- Mid Hudson Medical Research, New Windsor
- and 1 more
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.